Abstract
Despite rapid advances in early detection and therapies, breast cancer remains the leading cause of cancer death in women worldwide. The dismal prognosis of patients with breast cancer brain metastasis highlights the need to develop novel therapies to improve the poor survival. Recently described microRNAs (miRs or miRNAs) hold great promise in this regard. We interrogated the …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
